Verdiva Bio Limited ("Verdiva Bio" or "the Company"), a clinical-stage biotechnology company advancing a scalable, once-weekly oral obesity product pipeline, today announced that two abstracts have ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that three late-breaking abstracts highlighting its ...
A new study led by researchers at the UMass Amherst suggests that more than half of type 2 diabetes cases could be prevented ...
Rochester, N.Y. The Beer Coasters held their annual fundraiser to support the American Diabetes Association.
Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with T2DM by evaluating underlying mechanisms, treatment efficacy, medication safety profiles, and ...
Americans' household debt continued its steady climb to hit a record $18.8 trillion, according to the New York Fed's ...
Meanwhile in ATTAIN-MAINTAIN, patients who transitioned from injectable semaglutide or tirzepatide to the oral GLP-1 receptor ...
Quiz: Which blood tests matter most for aging adults? Most people know they should get blood work done. Fewer know what each ...
Multiancestry polygenic risk scores improve risk stratification for type 2 diabetes onset and complications across diverse ancestry groups.
Some of the most common diseases that impact our oral health include cavities (tooth decay), gum (periodontal) disease, and oral cancer.
A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...
Hypertensive disorders in pregnancy may lead to lasting cardiovascular issues in offspring, highlighting the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results